Amino Acid Supplement Improves Dysautonomia in a Fourteen-Year-Old Female
-
1
Carrick Institute, United States
Background:
A 14-year-old female presented with chief complaints of depression, fatigue, irritability, and insomnia.
Methods:
Neurological examination revealed increased sudomotor activity in hands and facial flushing. A five-minute heart rate variability study was performed which showed vagal dystonia (figure 1), decreased high-frequency heart rate variability of 2.8, and elevated mean heart rate of 117 bpm (figure 2).
She was placed on a very low dose of an amino acid supplement (glycerophosphocholine), approximately 10 mg, 2-3x per day and titrated up to 50 mg, 3x/day over the course of several weeks.
Results:
After 4 months of glycerophosphocholine supplementation, all symptoms were relieved with exception of insomnia with was incompletely improved. No facial flushing or abnormal sudomotor activity was noted. A five-minute heart rate variability study at this time showed balanced normotonia (figure 3), normal high-frequency heart rate variability of 5.6, and normal mean heart rate of 78 bpm (figure 4).
Conclusion:
Glycerophosphocholine supplementation might be useful in the management of dysautonomia. Further investigation into glycerophosphocholine supplementation in the treatment of patients with dysautonomia is suggested.
Keywords:
dysautonomia,
nutrition,
Depression,
supplementation,
Tachycardia
Conference:
International Symposium on Clinical Neuroscience 2018, Orlando, Florida, United States, 24 May - 26 May, 2018.
Presentation Type:
Poster
Topic:
Clinical Applications in health, disease, and injury to the nervous system
Citation:
Caffery
C
(2018). Amino Acid Supplement Improves Dysautonomia in a Fourteen-Year-Old Female.
Front. Neurol.
Conference Abstract:
International Symposium on Clinical Neuroscience 2018.
doi: 10.3389/conf.fneur.2018.60.00065
Copyright:
The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers.
They are made available through the Frontiers publishing platform as a service to conference organizers and presenters.
The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated.
Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed.
For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions.
Received:
31 Mar 2018;
Published Online:
14 Dec 2018.
*
Correspondence:
Dr. Chris Caffery, Carrick Institute, Cape Canaveral, United States, drcaffery@gmail.com